导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.90% | 489/1050 |
| 近一周 | 1.84% | 113/1104 |
| 近一月 | -8.84% | 1029/1103 |
| 近一季 | 8.83% | 104/1092 |
| 近半年 | 3.04% | 370/1070 |
| 近一年 | -16.45% | 836/1018 |
| 近两年 | 14.79% | 813/926 |
| 近三年 | -12.92% | 745/834 |
| 成立以来 | 5.72% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.36% 308/1070 |
8.09% 569/1101 |
- - |
- - |
| 2025 | 2.62% 911/1065 |
15.95% 45/1014 |
-1.17% 786/1038 |
7.34% 894/1050 |
-16.58% 999/1065 |
| 2024 | -22.40% 917/1011 |
-13.35% 871/960 |
-14.77% 935/983 |
17.84% 105/991 |
-10.83% 926/1011 |
| 2023 | -8.86% 293/952 |
2.07% 507/880 |
-2.83% 362/895 |
-10.55% 603/915 |
2.73% 48/952 |
| 2022 | -33.25% 685/867 |
-10.71% 125/773 |
-10.06% 772/806 |
-20.13% 755/845 |
4.07% 242/867 |
| 2021 | 4.67% 308/740 |
10.80% 8/580 |
25.17% 86/659 |
-16.14% 630/704 |
-10.01% 659/740 |
| 2020 | 74.02% 122/554 |
12.05% 34/419 |
41.73% 16/466 |
-4.49% 457/517 |
14.74% 211/554 |
| 2019 | 40.02% 219/410 |
31.02% 315/1146 |
-5.65% 752/1228 |
9.79% 116/390 |
3.18% 369/410 |
| 2018 | -14.26% 23/349 |
- - |
-0.64% 93/990 |
-5.28% 474/1000 |
-9.17% 230/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 金鹰医疗健康产业A VS. 东吴新产业精选股票A(580008) |